NovoCure Limited Ordinary Shares Earnings Dividend

NovoCure Limited Ordinary Shares’s revenue jumped 15.6% since last year same period to $183.58Mn in the Q2 2026. On a quarterly growth basis, NovoCure Limited Ordinary Shares has generated 5.47% jump in its revenue since last 3-months.

NovoCure Limited Ordinary Shares’s net profit jumped 60.99% since last year same period to $-15.66Mn in the Q2 2026. On a quarterly growth basis, NovoCure Limited Ordinary Shares has generated 77.99% jump in its net profits since last 3-months.

NovoCure Limited Ordinary Shares’s net profit margin jumped 66.26% since last year same period to -8.53% in the Q2 2026. On a quarterly growth basis, NovoCure Limited Ordinary Shares has generated 79.13% jump in its net profit margins since last 3-months.

NovoCure Limited Ordinary Shares’s earning per share (EPS) estimates for the current quarter stand at -0.25 - a 16.67% jump from last quarter’s estimates.

NovoCure Limited Ordinary Shares’s earning per share (EPS) estimates for the current year stand at -0.25.

NovoCure Limited Ordinary Shares’s earning per share (EPS) jumped 63.89% since last year same period to -0.13 in the Q2 2026. This indicates that the NovoCure Limited Ordinary Shares has generated 63.89% annual rate of jump in its earning per share (EPS) in the last 4 quarters.